Sano Genetics receives £330k grant for platform to support at-risk patients of neurodegenerative diseases
At-risk families of patients diagnosed with motor neurone disease (MND), better known in the US as amyotrophic lateral sclerosis (ALS) will now have access to genetic sequencing thanks to a financial award from Innovate UK.
